Amarin Corp Plc (AMRN)

[sstyles]

JT has alluded to the public health implication and the harm that could result if the public is not made aware of the benefits of Vascepa (limited market education).

The American Heart Association and the American Diabetes Association should submit amicus curiae briefs in addition to other organizations informing the judges of the unexpected results and medical need for Vascepa. Not to mention how non-obvious it was at the time. The question is will Amarin reach out to these organizations to solicit help? Time is of the essence.


Judges are human too and hearing from the ADA, AHA, and others could be beneficial to Amarin.

The public health aspect of this will likely be some component of the appeal (expedited nature as well). Although I hope there is a resolution as I am not looking forward to this hinging on the outcome of a trial. It will likely come down to the judges....very risky. We all know what happened the first time around. All comes down to the judges.